当前位置:
X-MOL 学术
›
Thorac. Cancer
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Prognostic impact of LILRB4 expression on tumor-infiltrating cells in resected non-small cell lung cancer
Thoracic Cancer ( IF 2.3 ) Pub Date : 2023-06-08 , DOI: 10.1111/1759-7714.14991
Sakiko Kumata, Hirotsugu Notsuda, Mei-Tzu Su, Ryoko Saito-Koyama, Ryota Tanaka, Yuyo Suzuki, Junichi Funahashi, Shota Endo, Isao Yokota, Toshiyuki Takai, Yoshinori Okada
Thoracic Cancer ( IF 2.3 ) Pub Date : 2023-06-08 , DOI: 10.1111/1759-7714.14991
Sakiko Kumata, Hirotsugu Notsuda, Mei-Tzu Su, Ryoko Saito-Koyama, Ryota Tanaka, Yuyo Suzuki, Junichi Funahashi, Shota Endo, Isao Yokota, Toshiyuki Takai, Yoshinori Okada
![]() |
Leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4/ILT3) is an up-and-coming molecule that promotes immune evasion. We have previously reported that LILRB4 facilitates myeloid-derived suppressor cells (MDSCs)-mediated tumor metastasis in mice. This study aimed to investigate the impact of the LILRB4 expression levels on tumor-infiltrating cells on the prognosis of non-small cell lung cancer (NSCLC) patients.
中文翻译:
LILRB4表达对切除的非小细胞肺癌肿瘤浸润细胞的预后影响
白细胞免疫球蛋白样受体 B 亚家族成员 4 (LILRB4/ILT3) 是一种新兴的促进免疫逃避的分子。我们之前报道过 LILRB4 促进小鼠骨髓源性抑制细胞 (MDSC) 介导的肿瘤转移。本研究旨在探讨肿瘤浸润细胞LILRB4表达水平对非小细胞肺癌(NSCLC)患者预后的影响。
更新日期:2023-06-08
中文翻译:

LILRB4表达对切除的非小细胞肺癌肿瘤浸润细胞的预后影响
白细胞免疫球蛋白样受体 B 亚家族成员 4 (LILRB4/ILT3) 是一种新兴的促进免疫逃避的分子。我们之前报道过 LILRB4 促进小鼠骨髓源性抑制细胞 (MDSC) 介导的肿瘤转移。本研究旨在探讨肿瘤浸润细胞LILRB4表达水平对非小细胞肺癌(NSCLC)患者预后的影响。